LeMaitre Vascular, Inc.

NasdaqGM LMAT

LeMaitre Vascular, Inc. Goodwill for the quarter ending September 30, 2024: USD 65.94 M

LeMaitre Vascular, Inc. Goodwill is USD 65.94 M for the quarter ending September 30, 2024, a 0.00% change year over year. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.
  • LeMaitre Vascular, Inc. Goodwill for the quarter ending September 30, 2023 was USD 65.94 M, a 0.00% change year over year.
  • LeMaitre Vascular, Inc. Goodwill for the quarter ending September 30, 2022 was USD 65.94 M, a 0.00% change year over year.
  • LeMaitre Vascular, Inc. Goodwill for the quarter ending September 30, 2021 was USD 65.94 M, a 0.00% change year over year.
  • LeMaitre Vascular, Inc. Goodwill for the quarter ending September 30, 2020 was USD 65.94 M, a 105.42% change year over year.
Key data
Date Goodwill Total Assets Current Liabilities Total Non-Current Liabilities
Market news
Loading...
SV Wall Street
NasdaqGM: LMAT

LeMaitre Vascular, Inc.

CEO Mr. George W. LeMaitre
IPO Date Oct. 19, 2006
Location United States
Headquarters 63 Second Avenue
Employees 614
Sector Healthcare
Industries
Description

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Similar companies

HAE

Haemonetics Corporation

USD 66.15

-4.20%

NVST

Envista Holdings Corp

USD 20.02

-2.44%

UTMD

Utah Medical Products, Inc.

USD 59.92

-2.14%

COO

The Cooper Companies, Inc.

USD 95.34

-1.25%

PDEX

Pro-Dex, Inc.

USD 35.30

-7.03%

KRMD

KORU Medical Systems, Inc.

USD 4.20

-4.33%

MLSS

Milestone Scientific Inc.

USD 1.20

-4.76%

ICUI

ICU Medical, Inc.

USD 158.69

-3.45%

HOLX

Hologic, Inc.

USD 71.72

-0.58%

INFU

InfuSystem Holdings, Inc.

USD 8.09

0.00%

StockViz Staff

February 6, 2025

Any question? Send us an email